跳至主要内容
临床试验/NL-OMON40251
NL-OMON40251已完成不适用

Pilot study Clip design A pilot study about the first use of the Elana Clip design to create intracranial anastomoses - Pilot study Clip design

niversitair Medisch Centrum Utrecht0 个研究点目标入组 5 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
5

研究概览

简要总结

Trial ended prematurely

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patient is > 18 years old on the date he/she signed the informed consent ;Patient requires a temporary or permanent bypass in the brain as determined by the physician.;From preoperative considerations it seems that the patient can provide a suitable donor graft which does not seem to be varicose, obliterated or stenosed and which can be expected to have a diameter compatible with the proximal and distal target vessel with sufficient length to bridge the distance from the proximal to distal anastomosis;Target vessels should have an outer diameter of at least 3mm

排除标准

  • Patient cannot be without clopidogrel (Plavix®) for the surgery and through discharge ;Patient participates in another clinical investigation that could confound the evaluation of the Study device;Patient is allergic to Aspirin;Surgeon believes the patient is an unsuitable surgical candidate because of a poor general state of health, which would not permit the required operating and anesthesia time (add at an appropriate safety margin - at least 50% - to the expected surgery time in the assessment) or because of abnormal blood coagulation values

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

已完成
不适用
A Phase 1 First-in-human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 330 Administered as Continuous Intravenous Infusion in Subjects With Myeloid Malignanciesbeenmergstoornis: MDS (myelodysplastisch syndroom/myelodysplasie)cancer of the blood10024324Acute myeloid leukemiamyelodysplastic Syndrome
NL-OMON55859Amgen10
已完成
不适用
A Global Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of the Half-life Extended Bispecific T-cell Engager AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancerscancer of stomachmaagkanker, kanker van de maag-slokdarmovergang, darm- en pancreaskanker1001799010017991stomach cancer
NL-OMON56431Amgen10
已完成
不适用
A prospective, multicenter clinical study to evaluate the safety profile of the FlexiSurge Adhesion Barrier for the prevention of intra-abdominal adhesion formation after laparotomyvorming van adhesies na buikchirurgieadhesion formationpostoperative adhesions
NL-OMON40303Medisse BV5
已完成
不适用
A Phase 1b, Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 plus Tilsotolimod and Other Therapy Combinations in Subjects with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NL-OMON49382AbbVie B.V.2
已完成
不适用
A two-part parallel group study to assess the safety, tolerability and pharmacokinetic (PK) profile of multiple oral doses of RDN-929 in healthy older adults and subjects with early symptomatic Alzheimer*s Diseaseneurodegenerative diseasesAlzheimer's Disease
NL-OMON48424Rodin Therapeutics, Inc.45